Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?
Weinshenker, Brian G. , Weinshenker, Brian G

Multiple Sclerosis Journal | September 11, 2015 | Volume: 21 | Issue: 13 | Pages: 1746-1747

10.1177/1352458515603801 | PMID 26362899 Get It

Whether or not recurrent tumefactive demyelinating lesions are a unique form of CNS demyelinating disease or part of the continuum of multiple sclerosis is a question raised by the case report on which this commentary is based. Detailed review and immunopathologic study of biopsy material may not only confirm or refute a diagnosis of demyelinating disease, but potentially uncover unique features that may assist in understanding pathophysiology and nosology of rare cases with recurrent tumefactive demyelination.
Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression
Kline, Timothy L. , Korfiatis, Panagiotis , Edwards, Marie E., Warner, Joshua , Irazabal, María V. , King, Bernard F., Torres, Vicente E. , Warner, Joshua D, Erickson, Bradley J. , Torres, Vicente E , Irazabal, Maria V

Nephrology Dialysis Transplantation | September 11, 2015 | Volume: 31 | Issue: 2 | Pages: 241-248

10.1093/ndt/gfv314 | PMID 26330562 Get It

Abstract Background Renal imaging examinations provide high-resolution information about the anatomic structure of the kidneys and are used to measure total kidney volume (TKV) in autosomal dominant polycystic kidney disease (ADPKD) patients. TKV has become the gold-standard image biomarker for ADPKD progression at early stages of the disease and is used in clinical trials to characterize treatment efficacy. Automated methods to segment the kidneys and measure TKV are desirable because of the long time requirement for manual approaches such as stereology or planimetry tracings. However, ADPKD kidney segmentation is complicated by a number of factors, including irregular kidney shapes and variable tissue signal at the kidney borders. Methods We describe an image processing approach that overcomes these problems by using a baseline segmentation initialization to provide automatic segmentation of follow-up scans obtained years apart. We validated our approach using 20 patients with complete baseline and follow-up T1-weighted magnetic resonance images. Both manual tracing and stereology were used to calculate TKV, with two observers performing manual tracings and one observer performing repeat tracings. Linear correlation and Bland–Altman analysis were performed to compare the different approaches. Results Our automated approach measured TKV at a level of accuracy (mean difference ± standard error = 0.99 ± 0.79%) on par with both intraobserver (0.77 ± 0.46%) and interobserver variability (1.34 ± 0.70%) of manual tracings. All approaches had excellent agreement and compared favorably with ground-truth manual tracing with interobserver, stereological and automated approaches having 95% confidence intervals ∼±100 mL. Conclusions Our method enables fast, cost-effective and reproducible quantification of ADPKD progression that will facilitate and lower the costs of clinical trials in ADPKD and other disorders requiring accurate, longitudinal kidney quantification. In addition, it will hasten the routine use of TKV as a prognostic biomarker in ADPKD.
Current Insights into the Pathogenesis of Graves’ Ophthalmopathy
Bahn, Rebecca S.

Hormone and Metabolic Research | September 11, 2015 | Volume: 47 | Issue: 10 | Pages: 773-778

10.1055/s-0035-1555762 | PMID 26361262 Get It

Abstract Environmental, genetic, and immune factors are at play in the development of the variable clinical manifestations of Graves’ ophthalmopathy (GO). Among the environmental contributions, smoking is the risk factor most consistently linked to the development or worsening of the disease. The close temporal relationship between the diagnoses of Graves’ hyperthyroidism and GO have long suggested that these 2 autoimmune conditions may share pathophysiologic features. The finding that the thyrotropin receptor (TSHR) is expressed in orbital fibroblasts, the target cells in GO, supported the notion of a common autoantigen. Both cellular and humeral immunity directed against TSHR expressed on orbital fibroblasts likely initiate the disease process. Activation of helper T cells recognizing TSHR peptides and ligation of TSHR by TRAb lead to the secretion of inflammatory cytokines and chemokines, and enhanced hyaluronic acid (HA) production and adipogenesis. The resulting connective tissue remodeling results in varying degrees extraocular muscle enlargement and orbital fat expansion. A subset of orbital fibroblasts express CD34, are bone-marrow derived, and circulate as fibrocytes that infiltrate connective tissues at sites of injury or inflammation. As these express high levels of TSHR and are capable of producing copious cytokines and chemokines, they may represent an orbital fibroblast population that plays a central role in GO development. In addition to TSHR, orbital fibroblasts from patients with GO express high levels of IGF-1R. Recent studies suggest that these receptors engage in cross-talk induced by TSHR ligation to synergistically enhance TSHR signaling, HA production, and the secretion of inflammatory mediators.
Faculty Opinions recommendation of SOX2 as a novel marker to predict neoplastic progression in Barrett's esophagus.
Iyer, P. K. R.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 11, 2015 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725760627.793509540 Get It

Faculty Opinions recommendation of Incidence of esophageal adenocarcinoma and causes of mortality after radiofrequency ablation of barrett's esophagus.
Iyer, Prasad G.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 11, 2015 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725764959.793509543 Get It

Cancer caregiver quality of life: need for targeted intervention
Atherton, Pamela J., Kung, Simon , Sloan, Jeff A. , Shahi, Varun, Clark, Matthew M. , Rummans, Teresa A. , Atherton, Philip J. , Lapid, Maria I. , Atherton, Pamela J., Atherton, Philip J.

Psycho-Oncology | September 11, 2015 | Volume: 25 | Issue: 12 | Pages: 1400-1407

10.1002/pon.3960 | PMID 26360934 Get It

AbstractObjectivesCaregiving can negatively impact well‐being. Cancer caregivers face unique challenges given the intense nature of cancer and treatment, which increases their risk for burden, poor quality of life (QOL), and burnout. Studies to reduce caregiver burden demonstrate QOL improvement and distress reduction in the short term. However, few studies exist to address long‐term benefits. We assessed changes in various QOL domains after participation in a QOL intervention for caregivers of patients having newly diagnosed advanced cancer.MethodsOur institutional review board‐approved study randomized patient–caregiver dyads to either usual care or an in‐person group intervention composed of six 90‐min sessions of structured multidisciplinary QOL components delivered over 4 weeks, with 10 follow‐up phone calls within 20 weeks. Caregivers attended four of the six sessions attended by patients. Sessions included physical therapy, coping and communication strategies, mental health education, spirituality, and social needs. Caregiver QOL (Caregiver Quality of Life Index‐Cancer Scale [CQOLC] and Linear Analogue Self‐Assessment [LASA]) and mood (Profile of Mood States‐Brief [POMS‐B]) were measured at baseline and 4, 27, and 52 weeks. Wilcoxon tests and effect sizes were used to compare the caregiver groups.ResultsOf the 131 caregivers (65 intervention and 66 usual care), 116 completed the study. Caregivers post‐intervention (at 4 weeks) had improved scores on LASA Spiritual Well‐being; POMS‐B total score, Vigor/Activity, and Fatigue/Inertia; and CQOLC Adaptation. At long term (at 27 weeks), caregivers retained improvement in POMS‐B Fatigue/Inertia and gained improvements in CQOLC Disruptiveness and Financial Concerns.ConclusionsCaregivers who received the intervention had higher QOL ratings for specific QOL domains but not for overall QOL. Although a comprehensive intervention was helpful, more specific, targeted interventions tailored for individual needs are recommended. Copyright © 2015 John Wiley & Sons, Ltd.
A novel objective method for deceased donor and recipient size matching in liver transplantation
Croome, Kristopher P. , Lee, David D. , Saucedo‐Crespo, Hector , Burns, Justin M. , Nguyen, Justin H. , Perry, Dana K. , Taner, C. Burcin , Croome, Kris P , Lee, David D

Liver Transplantation | September 11, 2015 | Volume: 21 | Issue: 12 | Pages: 1471-1477

10.1002/lt.24333 | PMID 26358746 Get It

Although the consequences of implantation of a large whole liver graft into a small recipient such as compression and compromise of graft perfusion are well known, no accepted measure to aid in donor‐to‐recipient size matching exists. Donor liver graft and recipient native liver weights as well as donor and recipient size and amount of ascites were investigated in 1953 patients who underwent liver transplantation using deceased donor grafts between January 2002 and July 2013. We used a previously described formula for liver resections (standardized total liver volume [sTLV] = –794.41 + 1267.28 × body surface area [m2]) for calculating sTLV, in the current cohort of deceased liver donors. Early allograft dysfunction (EAD) and graft survival were the primary outcome measures. The formula for calculating sTLV for liver resections was validated as an accurate predictor of liver volume in the current cohort of deceased liver donors (r2 = 0.45;P < 0.001). A cutoff point of sTLV ratio ≥ 1.25 was determined through receiver operating characteristic curves, and patients were dichotomized into 2 groups. In the sTLV ratio ≥ 1.25 group, 50% of patients developed EAD compared to 25% of patients in the sTLV ratio < 1.25 group (P < 0.001). The proportion of patients developing graft failure within 90 days was 9.6% in the sTLV ratio ≥ 1.25 group and 5.4% in the sTLV ratio < 1.25 group (P = 0.045). This study validates the use of the sTLV for prediction of actual donor liver weight in the transplant setting. Using this formula, donors with a calculated sTLV size ratio ≥ 1.25 have an increased risk of EAD and therefore caution should be used when that value is exceeded. This adjusted size ratio can be used as a decision aid when considering donor and recipient matching with potential liver organ offers.Liver Transpl 21:1471‐1477, 2015. © 2015 AASLD.
Graft‐versus‐host disease after orthotopic liver transplantation: multivariate analysis of risk factors
Elfeki, Mohamed A. , Pungpapong, Surakit , Genco, Petrina V., Nakhleh, Raouf E. , Nguyen, Justin H. , Harnois, Denise M. , Elfeki, Mohamed A. , Pungpapong, Surakit , Elfeki, Mohamed A

Clinical Transplantation | September 11, 2015 | Volume: 29 | Issue: 12 | Pages: 1063-1066

10.1111/ctr.12627 | PMID 26358521 Get It

AbstractGraft‐versus‐host disease (GVHD) is a rare, fatal complication following orthotopic liver transplantation (OLT). To date, several risk factors have been proposed, but reports on these factors have been inconclusive. This is a retrospective, case–control study of prospectively collected data from 2775OLTs performed at our institution. Eight cases ofGVHDafterOLTwere diagnosed on the basis of the patient's clinical characteristics, and the findings were confirmed with skin and colonic biopsies. Each case was matched to three controls based on the diagnosis of liver disease, recipient's age, and blood group. Univariate and multivariate analyses were performed to identify risk factors associated with the development ofGVHDafterOLT. The univariate and multivariate analyses identified two main risk factors associated with development ofGVHDinOLTrecipients, a difference between recipient and donor age of >20 yr, and any human leukocyte antigen classImatches. Taking these two risk factors into consideration while matching prospective donors and recipients may reduce further incidence ofGVHDinOLTpatients. However, further studies are recommended to validate these findings.
Lesion Size and Safety Comparison Between the Novel Flex Tip on the FlexAbility Ablation Catheter and the Solid Tips on the ThermoCool and ThermoCool SF Ablation Catheters
Winterfield, Jeffrey R. , Jensen, James A., GILBERT, THERESE, Natale, Andrea , Packer, Douglas L. , Reddy, Vivek Y. , Mahapatra, Srijoy, Wilber, David J. , Packer, Douglas, Marchlinski, Francis E. , Natale, Andrea , Reddy, Vivek Y

Journal of Cardiovascular Electrophysiology | September 11, 2015 | Volume: 27 | Issue: 1 | Pages: 102-109

10.1111/jce.12835 | PMID 26359632 Get It

Flex Tip Comparative AblationIntroductionNext‐generation catheters have been developed to reduce irrigation volume and preserve power delivery. A novel design uses a flexible tip (FlexAbility™ catheter) that directs flow to the contact surface. Because of recent safety issues with new catheters, we undertook a study in a canine heart with 3 irrigated catheters to compare efficacy and safety.MethodsEndocardial ablation was performed by 2 independent operators in 12 anesthetized canines with the FlexAbility (St. Jude Medical), ThermoCool™ (Biosense Webster), and ThermoCool™ SF (Biosense Webster) catheters. Endocardial RF lesions were delivered with each catheter in all 4 chambers of each animal for 52 ± 16 seconds. Each chamber was randomized to receive ablation from one catheter with recording of safety events. Cardiac pathology was performed with triphenyl tetrazolium chloride stain.ResultsAverage lesion dimensions were not significantly different between the 3 catheters. FlexAbility™ demonstrated a lower risk of steam pops relative to ThermoCool SF (P‐value = 0.013) despite equal mean power and radiofrequency time. High‐temperature generator shutdowns were observed with FlexAbility™ but not with either ThermoCool catheter. High‐temperature shutdowns were associated with larger average impedance drops (28.5 ohms vs. 19 ohms) without compromising lesion size.ConclusionsThe FlexAbility™ tip is safe and effective with no significant difference in lesion sizes compared to both standard ThermoCool and ThermoCool SF. FlexAbility™ has a significantly lower risk of steam pops compared to ThermoCool SF in a beating heart as defined predominantly by an abrupt rise of impedance.
Moving Beyond Cardio-Centricity in Heart Failure Risk Stratification
Borlaug, Barry A. , Borlaug, Barry A

Circulation | September 11, 2015 | Volume: 132 | Issue: 17 | Pages: 1602-1603

10.1161/circulationaha.115.018951 | PMID 26358262 Get It